Sanofi

Showing 15 posts of 579 posts found.

Zaltrap image

Zaltrap ‘no’ from NICE

June 21, 2013
Sales and Marketing NICE, Sanofi, Zaltrap

NICE is preparing to discard Sanofi’s Zaltrap as an NHS option for treating metastatic colorectal cancer (mCRC) that is resistant …

Sanofi image

Sanofi makes Curie cancer deal

June 20, 2013
Research and Development, Sales and Marketing Cancer, R&D, Sanofi, curie

Sanofi has signed a three-year research collaboration with the Curie Institute to identify new therapeutic targets which will help develop …

Sanofi admits $285m failure

June 4, 2013
Research and Development, Sales and Marketing Sanofi, its benzamide iniparib, otamixaban

Sanofi has consigned two investigational drugs to the corporate dustbin, preferring a $285 million dent in its coffers to continuing …

Positive news for Sanofi asthma drug

May 23, 2013
Sales and Marketing Dupilumab, Regeneron, Sanofi, asthma

An asthma drug being developed by Sanofi and Regeneron Pharmaceuticals has performed well in a Phase IIa trial, reducing the …

Sanofi image

Sanofi’s performance dives

May 3, 2013
Sales and Marketing Q1, Sanofi

Sanofi suffered a grim first three months of 2013, with sales dipping and profit plummeting as loss of exclusivity took …

28569_guenter_100

Sanofi appoints two executive members

May 3, 2013
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Sanofi, executive

Sanofi has announced a new commercial organisation which results in the appointment of two executives. Following the retirement of Hanspeter …

Sanofi reinforces presence in Morocco

April 19, 2013
Manufacturing and Production Morocco, Sanofi, emerging markets, logistics

Sanofi has opened a new logistics hub in Morocco to help it increase and accelerate distribution of its medicines throughout …

Sanofi earmarks $75m for Vietnamese plant

April 19, 2013
Manufacturing and Production Sanofi, vietnam

Sanofi has broken ground on a new manufacturing facility in Ho Chi Minh City, Vietnam, as part of its push …

sanofi_hq_reception_close

Zaltrap launched in UK

March 4, 2013
Sales and Marketing Sanofi, Zaltrap

Sanofi and Regeneron Pharmaceuticals’ bowel cancer drug Zaltrap has been launched in the UK today. Zaltrap (aflibercept) will be used …

Genzyme’s Waterford plant gets new investment round

February 19, 2013
Manufacturing and Production Genzyme, Sanofi, Waterford

Sanofi’s Genzyme unit plans to spend €44 million on upgrading its plant in Waterford, Ireland, to help meet demand for …

screen_shot_2013-02-15_at_14

Nanobiotix appoints ex-Sanofi head Alain Herrera

February 14, 2013
Manufacturing and Production, Research and Development, Sales and Marketing Sanofi, nanobiotix

Nanomedicine firm Nanobiotix has announced that Dr Alain Herrera joins its Supervisory Board, succeeding Thierry Chopin and Isabelle Bou Antoun …

regeneron image

Sanofi ups stake in Regeneron

February 13, 2013
Sales and Marketing AMD, Regeneron, Sanofi, Zaltrap

Sanofi is increasing its stake in Regeneron Pharmaceuticals by buying shares on the open market and from existing shareholders. The …

Sanofi won’t follow trend for spin-offs

February 8, 2013
Sales and Marketing Abbott, Pfizer, Sanofi, Viehbacher

Sanofi’s chief executive Chris Viehbacher says the firm plans to maintain its portfolio of business divisions for the foreseeable future, …

Sanofi celebrates EU approvals

February 5, 2013
Sales and Marketing Lyxumia, Sanofi, Zaltrap, diabetes

Sanofi is celebrating after diabetes treatment Lyxumia (lixisenatide) and metastatic colorectal cancer (mCRC) drug Zaltrap received authorisation in Europe. The …

Sanofi global operations president to retire

December 20, 2012
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Hanspeter Spek, Sanofi

Sanofi has announced that Hanspeter Spek, president, Global Operations, will retire from his current role in mid-2013. Christopher Viehbacher, chief executive …

The Gateway to Local Adoption Series

Latest content